Phase I Study Of P-Glycoprotein (P-gp) Mediated Drug Interactions Between Lenalidomide (LEN) and Quinidine Or Temsirolimus

被引：1
|
作者：
Chen, Nianhang
Weiss, Daniel
Reyes, Josephine
Liu, Liangang
Kasserra, Claudia
Wang, Xiaomin
Zhou, Simon
Kumar, Gondi
Weiss, Lilia
Palmisano, Maria
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.5395.5395
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5395
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The contribution of P-glycoprotein to clinical pharmacokinetic interactions between lenalidomide and temsirolimus
    Yang, Xiaoxia
    Craig, Hofmeister C.
    Rozewski, Darlene M.
    Lee, Seungsoo
    Chen, Ping
    Johnson, Amy J.
    Liu, Zhongfa
    Hade, Erinn M.
    Ji, Jia
    Schaaf, Larry J.
    Benson, Don M.
    Kraut, Eric H.
    Hicks, William J.
    Chan, Kenneth K.
    Chen, Ching-Shih
    Farag, Sherif S.
    Grever, Michael R.
    Byrd, John C.
    Phelps, Mitch A.
    CANCER RESEARCH, 2011, 71
  • [2] Relationship between P-glycoprotein (P-gp) mediated digoxin clearance and expressed P-gp levels in vitro.
    Tirona, RG
    Kim, RB
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P87 - P87
  • [3] CHOLESTATIC STEROID GLUCURONIDES - INTERACTIONS WITH P-GLYCOPROTEIN (P-GP)
    VORE, M
    GOSLAND, M
    TSUBOI, C
    HOFFMAN, T
    HEPATOLOGY, 1993, 18 (04) : A139 - A139
  • [4] P-GLYCOPROTEIN (P-GP) AND DRUG-RESISTANCE - TIME FOR REAPPRAISAL
    KAYE, SB
    BRITISH JOURNAL OF CANCER, 1993, 67 (04) : 641 - 643
  • [5] Effect of P-glycoprotein (P-gp) Inducers on Exposure of P-gp Substrates: Review of Clinical Drug–Drug Interaction Studies
    Mohamed Elmeliegy
    Manoli Vourvahis
    Cen Guo
    Diane D. Wang
    Clinical Pharmacokinetics, 2020, 59 : 699 - 714
  • [6] Circadian changes in intestinal secretion: Drug-drug interactions with the P-glycoprotein (P-gp) substrate talinolol
    Okyar, A.
    Baktir, G.
    Spahn-Langguth, H.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2008, 377 : 62 - 62
  • [7] Inhibitory effects of herbal constituents on P-glycoprotein in vitro and in vivo: Herb-drug interactions mediated via P-gp
    Li, Xue
    Hu, Jinping
    Wang, Baolian
    Sheng, Li
    Liu, Zhihao
    Yang, Shuang
    Li, Yan
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2014, 275 (02) : 163 - 175
  • [8] Effect of P-glycoprotein (P-gp) Inducers on Exposure of P-gp Substrates: Review of Clinical Drug-Drug Interaction Studies
    Elmeliegy, Mohamed
    Vourvahis, Manoli
    Guo, Cen
    Wang, Diane D.
    CLINICAL PHARMACOKINETICS, 2020, 59 (06) : 699 - 714
  • [9] IS INHIBITION OF P-GLYCOPROTEIN (P-GP) SUBSTRATE DEPENDENT?
    Louie, Steven W.
    Hsiao, Peng
    Unadkat, Jashvant D.
    DRUG METABOLISM REVIEWS, 2014, 45 : 252 - 253
  • [10] DETECTION AND LOCALIZATION OF P-GLYCOPROTEIN (P-GP) IN THE KIDNEY
    TOBE, S
    LIEBERMAN, D
    GOLDBERG, H
    SKORECKI, K
    REITHMEIER, R
    KIDNEY INTERNATIONAL, 1990, 37 (01) : 234 - 234
12345